简介内容:AMXI-5001 is a potent, orally active inhibitor of parp1/2 and microtubule aggregation. mxi-5001 shows selective anti-tumour cytotoxicity against a wide range of human cancer cells with IC50s well below those of existing clinical PARP1/2 inhibitors. amxi-5001 induces complete regression of established tumours, including very large ones.